Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $88,698.47 +1.35%
Ethereum $3,003.87 +1.17%
BNB $862.86 -0.11%
Optimism $0.30 +10.25%
Arbitrum $0.20 +7.39%
Solana $126.89 +1.78%
Polygon $0.22 +2.77%
Cosmos $2.06 +7.12%
Avalanche $13.58 +10.18%

Bitcoin $88,698.47 +1.35%
Ethereum $3,003.87 +1.17%
BNB $862.86 -0.11%
Optimism $0.30 +10.25%
Arbitrum $0.20 +7.39%
Solana $126.89 +1.78%
Polygon $0.22 +2.77%
Cosmos $2.06 +7.12%
Avalanche $13.58 +10.18%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B